Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

By | December 31, 2021
Researchers investigated the potency of trimeric human nephrocystin SH3, TriSb92, a domain-derived antibody, against a conserved region in the receptor-binding domain (RBD) of the spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern.